Direkt zum Inhalt
Merck
  • Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population.

Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population.

Circulation research (2006-07-15)
Natalie Gude, John Muraski, Marta Rubio, Jan Kajstura, Erik Schaefer, Piero Anversa, Mark A Sussman
ZUSAMMENFASSUNG

Activation of Akt is associated with enhanced cell cycling and cellular proliferation in nonmyocytes, but this effect of nuclear Akt accumulation has not been explored in the context of the myocardium. Cardiac-specific expression of nuclear-targeted Akt (Akt/nuc) in transgenics prolongs postnatal cell cycling as evidenced by increased numbers of Ki67+ cardiomyocytes at 2 to 3 weeks after birth. Similarly, nuclear-targeting of Akt promotes expansion of the presumptive cardiac progenitor cell population as assessed by immunolabeling for c-kit in combination with myocyte-specific markers Nkx 2.5 or MEF 2C. Increases in pro-proliferative cytokines, including tumor-necrosis superfamily 8, interleukin-17e, and hepatocyte growth factor, were found in nuclear-targeted Akt myocardial samples. Concurrent signaling mediated by paracrine factors downstream of Akt/nuc expression may be responsible for phenotypic effects of nuclear-targeted Akt in the myocardium, including enhanced cell proliferation and expansion of the stem cell population.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Monoclonal Anti-Tropomyosin (Sarcomeric) antibody produced in mouse, clone CH1, ascites fluid